PHR1817
Furosemid-verwandte Verbindung A
Pharmaceutical Secondary Standard; Certified Reference Material
Synonym(e):
2-Chlor-4-furfurylamino-5-sulfamoyl-benzoesäure
About This Item
Empfohlene Produkte
Qualität
certified reference material
pharmaceutical secondary standard
Qualitätsniveau
Agentur
traceable to Ph. Eur. F0702000
traceable to USP 1287020
Analysenzertifikat (CofA)
current certificate can be downloaded
Verpackung
pkg of 100 mg
mp (Schmelzpunkt)
197 °C (dec.) (lit.)
Anwendung(en)
pharmaceutical
Format
neat
Lagertemp.
2-30°C
SMILES String
OC(C1=C(Cl)C=C(NCC2=CC=CO2)C(S(N)(=O)=O)=C1)=O
InChI
1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)11(21(14,18)19)4-8(9)12(16)17/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
InChIKey
UXOOVYKVEXGCSH-UHFFFAOYSA-N
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Allgemeine Beschreibung
Anwendung
- Furosemide Impurity A for Quality Control: Furosemide Related Compound A serves as a crucial standard in pharmaceutical quality control, ensuring the purity and safety of furosemide as an active pharmaceutical ingredient. This impurity standard is essential for regulatory compliance and batch-to-batch consistency in drug manufacturing (Abasilim et al., 2023).
- Research on Drug Resistance: Furosemide Related Compound A is utilized in genomic research to identify potential drug resistance mechanisms. This research aids in understanding how bacterial pathogens develop resistance to drugs like clarithromycin and rifampicin, which is crucial for developing new therapeutic strategies (Mofidifar et al., 2024).
- Nanotechnology in Drug Delivery: High-purity Furosemide Related Compound A is used in the preparation and characterization of novel drug delivery systems, such as nanoparticles designed to enhance the bioavailability and efficacy of pharmaceutical compounds. This research highlights its application in improving drug formulations and targeting specific disease sites (Zeng et al., 2024).
- Impact on Bone Health: Research involving Furosemide Related Compound A explores its effects on bone health, particularly in how it influences vitamin D metabolism and bone density. This is vital for developing treatments that mitigate bone density loss associated with long-term use of diuretics like furosemide (Melanie KF et al., 2024).
- Nutritional Studies in Cancer Therapy: Furosemide Related Compound A is also examined for its role in nutritional interventions in cancer therapy, particularly its impact on the nutritional status of patients undergoing surgery for colorectal cancer. These studies are crucial for understanding how nutritional support can enhance recovery and treatment outcomes in cancer patients (Ural et al., 2024).
Hinweis zur Analyse
Sonstige Hinweise
Fußnote
Empfohlene Produkte
Lagerklassenschlüssel
11 - Combustible Solids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Choose from one of the most recent versions:
Analysenzertifikate (COA)
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.